alexa
Reach Us +44-1904-929220
Targeting HER2-Driven Cancers in Non-Breast Cancer Malignancies | OMICS International | Abstract
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Targeting HER2-Driven Cancers in Non-Breast Cancer Malignancies

Simon P Langdon*

Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK

*Corresponding Author:
Simon P Langdon
Breakthrough Breast Unit and Division of Patholog
Institute of Genetics and Molecular Medicine
University of Edinburgh, Western General Hospital
Crewe Road South, Edinburgh EH4 2XU, UK
E-mail: [email protected]

Received date: February 25, 2012; Accepted date: March 02, 2012; Published date: March 04, 2012

Citation: Langdon SP (2012) Targeting HER2-Driven Cancers in Non-Breast Cancer Malignancies. J Mol Biomark Diagn 3:e105. doi:10.4172/2155-9929.1000e105

Copyright: © 2012 Langdon SP. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Recommended Conferences

15th Global Biomarkers and Clinical Research Summit

Vienna, Austria

2nd International Conference on Biomarkers and Cancer Targets

Capetown, South Africa
Share This Page
Top